DGX — Quest Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00
- $15.81bn
- $20.16bn
- $9.25bn
- 89
- 55
- 91
- 92
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 906 | 1,499 | 2,080 | 1,015 | 908 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -42 | 38 | -285 | 146 | 119 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 35 | 22 | 87 | 119 | -145 |
Change in Accounts Receivable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 1,243 | 2,005 | 2,233 | 1,718 | 1,272 |
Capital Expenditures | -400 | -418 | -403 | -404 | -408 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -11 | -354 | 424 | -139 | -653 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Cash from Investing Activities | -411 | -772 | 21 | -543 | -1,061 |
Financing Cash Flow Items | -87 | -29 | -159 | -140 | -71 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 225 | -1,267 | -2,540 | -1,732 | 160 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1,057 | -34 | -286 | -557 | 371 |